Back to search

Article

A New Blood-Based Epigenetic Diagnostic Biomarker Test (Episwitch® NST) with High Sensitivity and Positive Predictive Value for Colorectal Cancer and Precancerous Polyps

2024-12-10

Abstract excerpt

<h4>Background: </h4> /Objectives Colorectal cancer (CRC) arises from the epithelial lining of the colon or rectum, often following a progression from benign adenomatous polyps to malignant carcinoma. Screening modalities such as colonoscopy, faecal immunochemical tests (FIT), and FIT-DNA are critical for early detection and prevention, but non-invasive methods lack sensitivity to polyps and early CRC. Chromosome...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
809df2f2-eee4-5f7e-b3a0-19a10658154a
DOI
10.20944/preprints202412.0872.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A New Blood-Based Epigenetic Diagnostic Biomarker Test (Episwitch® NST) with High Sensitivity and Positive Predictive Value for Colorectal Cancer and Precancerous PolypsDOI 10.20944/preprints202412.0872.v1
Select a neighboring publication to make it the new centre.